This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (72) Citing Articles via Google Scholar Google Scholar Articles by Montgomery, L. L. Articles by Borgen, P. I. Search for Related Content PubMed PubMed Citation Articles by Montgomery, L. L. Articles by Borgen, P. I. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer

Leslie L. Montgomery, MD^*, Alisa C. Thorne, MD, Kimberly J. Van Zee, MS MD^*, Jane Fey, MPH^*, Alexandra S. Heerdt, MD MPH^*, Mary Gemignani, MD^*, Elisa Port, MD^*, Jeanne Petrek, MD^*, Hiram S. Cody, III, MD^*, and Patrick I. Borgen, MD^*

*Breast Service, Department of Surgery, and Department of Anesthesia, Memorial Sloan-Kettering Cancer Center, New York, New York

Address correspondence and reprint requests to Leslie L. Montgomery, MD, MSKCC-MRI 1026, 1275 York Ave., New York, NY 10021. Address e-mail to montgoml{at}mskcc.org

In the United States, identification of the sentinel lymph node (SLN) requires the use of ^99mTc-labeled colloid, 1% isosulfan blue dye, or both to trace the lymphatic drainage of a given neoplasm. We report our experience with adverse reactions to isosulfan blue dye during SLN mapping in breast cancer. A chart review of the breast cancer SLN database was performed; it included 2392 sequential patients who underwent SLN biopsy involving isosulfan blue dye at Memorial Sloan-Kettering Cancer Center from September 12, 1996, to August 17, 2000. Thirty-nine of 2392 patients (1.6%) had a documented allergic reaction during the mapping procedure. Most reactions (69%) produced urticaria, blue hives, a generalized rash, or pruritus. The incidence of hypotensive reactions was 0.5%. Although anaphylaxis after the injection of isosulfan blue dye is rare, this article highlights the need to suspect anaphylaxis when hemodynamic instability occurs after the injection of this compound. Our experience indicates that bronchospasm and respiratory compromise are unusual and that most patients do not require emergent intubation and can be managed with short-term pressor support. In addition, our data indicate that patients with a sulfa allergy do not display a cross-sensitivity to isosulfan blue dye.

IMPLICATIONS: We report the largest single-institution review of adverse reactions to injection of isosulfan blue dye during sentinel lymph node mapping in breast cancer. Bronchospasm and respiratory compromise are unusual, and most patients can be treated with short-term pressor support. Patients with a sulfa allergy do not display a cross-sensitivity to isosulfan blue dye.

This article has been cited by other articles:

				S. M. Anand, O. Gologan, L. Rochon, M. Tamilia, J. How, M. P. Hier, M. J. Black, K. Richardson, H. A. Hakami, H. Z. Marzouki, et al. The Role of Sentinel Lymph Node Biopsy in Differentiated Thyroid Carcinoma Arch Otolaryngol Head Neck Surg, December 1, 2009; 135(12): 1199 - 1204. [Abstract] [Full Text] [PDF]

				S. K. Somasundaram, D. W. Chicken, and M. R. S. Keshtgar Detection of the sentinel lymph node in breast cancer Br. Med. Bull., January 3, 2008; (2008) ldm032v1. [Abstract] [Full Text] [PDF]

				G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer J. Clin. Oncol., October 20, 2005; 23(30): 7703 - 7720. [Abstract] [Full Text] [PDF]

				M Currie, R K Kerridge, A K Bacon, and J A Williamson Crisis management during anaesthesia: anaphylaxis and allergy Qual. Saf. Health Care, June 1, 2005; 14(3): e19 - e19. [Abstract] [Full Text] [PDF]

				H. Osaka, M. Yashiro, T. Sawada, K. Katsuragi, and K. Hirakawa Is a Lymph Node Detected by the Dye-Guided Method a True Sentinel Node in Gastric Cancer? Clin. Cancer Res., October 15, 2004; 10(20): 6912 - 6918. [Abstract] [Full Text] [PDF]

				A. D. Axon and J. M. Hunter Editorial III: Anaphylaxis and anaesthesia--all clear now? Br. J. Anaesth., October 1, 2004; 93(4): 501 - 504. [Full Text] [PDF]

				C. P. Raut, M. D. Daley, K. K. Hunt, J. Akins, M. I. Ross, S. E. Singletary, G. D. Marshall Jr, F. Meric-Bernstam, G. Babiera, B. W. Feig, et al. Anaphylactoid Reactions to Isosulfan Blue Dye During Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis J. Clin. Oncol., February 1, 2004; 22(3): 567 - 568. [Full Text] [PDF]

				J. Sprung, M. J. Tully, and A. Ziser Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer Anesth. Analg., April 1, 2003; 96(4): 1051 - 1053. [Abstract] [Full Text] [PDF]